Amanote Research
Register
Sign In
Characterization of Peptide Aptamers to the Anterior Gradient 2: A Novel Inhibitor of the Tumour Suppressor Protein P53
Breast Cancer Research
- United Kingdom
doi 10.1186/bcr1565
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
November 1, 2006
Authors
A Fourtouna
E Murray
L Hayward
L Pohler
T Hupp
Publisher
Springer Science and Business Media LLC
Related search
The DEAD Box Protein P68: A Novel Transcriptional Coactivator of the P53 Tumour Suppressor
EMBO Journal
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Tumour Suppressor Protein P53 Regulates the Stress Activated Bilirubin Oxidase Cytochrome P450 2A6
Toxicology and Applied Pharmacology
Toxicology
Pharmacology
Novel Phosphorylation Sites of Human Tumour Suppressor Protein P53 at Ser20 and Thr18 That Disrupt the Binding of Mdm2 (Mouse Double Minute 2) Protein Are Modified in Human Cancers
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Shaping the Regulation of the P53 mRNA Tumour Suppressor: The Co-Evolution of Genetic Signatures
BMC Cancer
Cancer Research
Oncology
Genetics
Tumour Suppressor P53 Inhibits Human Fibroblast Growth Factor 2 Expression by a Post-Transcriptional Mechanism
Oncogene
Cancer Research
Genetics
Molecular Biology
Fuse Binding Protein Antagonizes the Transcription Activity of Tumor Suppressor Protein P53
BMC Cancer
Cancer Research
Oncology
Genetics
D133p53 Isoform Is a Direct P53 Target Gene That Modulates P53 Tumour Suppressor Activity
Breast Cancer Research
Cancer Research
Oncology
A Dimethylbromobenzene-Cysteine Stapled Peptide Dual Inhibitor of the P53-Mdm2/MDMX Interactions
Hepatoma Research
Tumor Suppressor Protein P53 Binds Preferentially to Supercoiled DNA
Oncogene
Cancer Research
Genetics
Molecular Biology
